View of Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate

Return to Article Details Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate Download Download PDF